Tailored Health Literacy Follow-up in Cancer
Launched by LOVISENBERG DIAKONALE HOSPITAL · Nov 23, 2022
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Tailored Health Literacy Follow-up in Cancer," is focused on helping people with cancer better understand and manage their health information and care. Health literacy is important because it affects how well patients can navigate their treatment, understand their symptoms, and make informed decisions about their health. The study is looking to see how effective a special follow-up program is, where nurses provide personalized support through phone calls, digital communication, or in-person meetings. This support will address each patient’s unique needs, aiming to improve their quality of life, reduce symptoms, and lower healthcare costs.
To participate in this trial, you must be at least 18 years old, diagnosed with cancer, and receiving treatment at the hospital where the study is taking place. If you join, you can expect to receive tailored support that helps you manage your health better. The trial is currently recruiting participants, and it welcomes individuals of all genders within the specified age range. This study is an opportunity to enhance your understanding of your health and improve your overall care experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with cancer
- • Above 18 years old
- • Receiving treatment at the main intervention hospital
- Exclusion Criteria:
- • Not diagnosed with cancer
- • Not above 18 years old
- • Not in treatment at the intervention hospital
About Lovisenberg Diakonale Hospital
Lovisenberg Diakonale Hospital is a reputable healthcare institution located in Oslo, Norway, dedicated to providing high-quality medical care and advancing clinical research. As a clinical trial sponsor, the hospital is committed to fostering innovation in medical treatments and improving patient outcomes through rigorous scientific investigation. With a multidisciplinary team of healthcare professionals and researchers, Lovisenberg Diakonale Hospital prioritizes ethical standards, patient safety, and collaboration with various stakeholders to facilitate groundbreaking studies that address pressing health challenges. The hospital's focus on compassionate care and evidence-based practices positions it as a leader in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Christine R Borge, PhD
Principal Investigator
Lovisenberg Diaconal Hospital and University of Oslo
Astrid K Wahl, PhD
Study Chair
University of Oslo
Simen A Steindal, PhD
Study Chair
VID
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials